Thrombosis has become one of the major diseases harmful to human health. The new‐
generation thrombolytic drug nattokinase (NK) has been used in the treatment of thrombosis …

Nattokinase (NK) has been used as a new generation thrombolytic drug, due to its high
safety, low cost and low side effects. However, it is sensitive to external environment and …

Thrombotic disease has become one of the leading causes of mortality among humans
globally. Nattokinase (NK), a novel thrombolytic agent, has attracted the attention of …

Thrombotic events affect many individuals in a number of ways, all of which can cause
significant morbidity and mortality. Nattokinase (NK), as a novel thrombolytic drug, has been …

With the frequent occurrence of thrombus diseases, thrombus has become a factor
endangering human health. Nattokinase (NK) is a new generation of thrombolytic drug with …

Cardiovascular disease (CVD) has become the leading cause of death globally. Nattokinase
(NK), as a novel thrombolytic agent, has gained more and more attention. However, NK is …

Nattokinase (NK) is a thrombolytic enzyme extracted from natto, which can be used to
prevent and treat blood clots. However, it is sensitive to the environment, especially the …

Thrombus-related diseases have a high mortality rate and are seriously threatening human
life and health. Nattokinase (NK), which has a strong thrombolytic effect, can treat thrombotic …

Nattokinase is a promising thrombolytic drug due to its powerful fibrinolytic effect and few
side effects. However, the low fibrinolytic activity and stability of nattokinase have limited its …

The present research work describes the downstreaming of nattokinase (NK) produced by
Bacillus subtilis under solid state fermentation; and the role of efficient oral formulation of …